-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUMORA THERAPEUTICS - 30 MG BID DOSE OF NMRA-511 SHOWS FAVORABLE SAFETY WITH NO SERIOUS ADVERSE EVENTS

Reuters·11/16/2026 13:00:05

Please log in to view news